Hydroxychloroquine Tied to Increased Risk of Death in COVID-19 Patients
(Reuters)—Malaria drug hydroxychloroquine (HCQ), which U.S. President Donald Trump says he has been taking, is tied to increased risk of death in COVID-19 patients, according to a study published in The Lancet.1 The registry analysis, which included data from 671 hospitals in six continents and over 96,000 patients hospitalized with COVID-19, showed that people treated... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Reuters Staff Tags: Drug Updates coronavirus COVID-19 death HCQ Hydroxychloroquine (HCQ) Source Type: research
More News: American Health | Coronavirus | COVID-19 | Hospitals | Hydroxychloroquine | Malaria | Rheumatology | Study | Trump | USA Health